バイオ分析検査サービス市場規模、シェア、成長分析：分子別、検査別、ワークフロー別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

バイオ分析検査サービス市場規模は2023年に36億米ドルと評価され、2024年の41億8,000万米ドルから2032年には139億米ドルに成長し、予測期間（2025-2032年）のCAGRは16.2%で成長する見通しです。

世界のバイオ分析検査サービス市場には、製薬、バイオ医薬品、バイオテクノロジー業界に提供され、医薬品開発と研究をサポートする分析サービスが含まれます。これらのサービスでは、血液、尿、組織などの生体サンプルを分析して薬物濃度、代謝物、バイオマーカーを測定し、それによって薬物の安全性、有効性、薬物動態を評価します。これらの重要なサービスを提供する上で、CRO（医薬品開発業務受託機関）や専門サービスプロバイダーは極めて重要な役割を果たしています。バイオ分析検査サービス市場の主な目的は、安全で効果的な医薬品の市場導入を促進するために、信頼性の高い正確な試験を提供することです。しかし、いくつかの課題が市場の成長を妨げています。特に、バイオ分析検査サービスに関連する高額なコストは、特に小規模の製薬会社や研究機関にとっては法外なものです。さらに、バイオ分析試験特有の複雑さや技術的な難しさは、結果の効率性や正確性を制限し、納期の延長やデータ解釈の潜在的な問題につながる可能性があります。さらに、分析方法や手順が標準化されていないことも大きな課題となっています。手法のばらつきはデータの矛盾につながり、異なる研究や研究室間での結果の比較や検証を複雑にします。このような統一性の欠如は、医薬品開発プロセスを妨げ、規制当局の承認を遅らせる可能性があります。このような課題に対処するには、分析法の標準化、プロセスを合理化するための先端技術への投資、費用対効果の高い戦略の導入など、一致団結した取り組みが必要です。このような対策は、既存の障壁を克服し、バイオ分析検査サービス市場の成長を促進するために不可欠です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

バイオ分析検査サービス市場規模：分子別& CAGR（2025-2032）

• 市場概要
• 小分子
• 巨大分子
  • LC-MS研究
  • 免疫測定
  • PK
  • ADA
  • その他
• その他

バイオ分析検査サービス市場規模：検査別& CAGR（2025-2032）

• 市場概要
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• 生物学的利用能
• 生物学的同等性
• その他

バイオ分析検査サービス市場規模：ワークフロー別& CAGR（2025-2032）

• 市場概要
• サンプル調製
  • タンパク質沈殿
  • 液液抽出
  • 固相抽出
• サンプル分析
  • ハイフネーテッド技術
  • クロマトグラフィー技術
  • 電気泳動
  • リガンド結合アッセイ
  • 質量分析
  • 核磁気共鳴
• その他のワークフロープロセス

バイオ分析検査サービス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 腫瘍学
• 神経学
• 感染症
• 消化器内科
• 心臓病学
• その他の用途

バイオ分析検査サービス市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 製薬・バイオ医薬品企業
• CDMO
• CRO

バイオ分析検査サービス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Charles River Laboratories（USA）
• Labcorp Drug Development（USA）
• Eurofins Scientific（Luxembourg）
• SGS S.A.（Switzerland）
• PPD, Inc.
• ICON plc（Ireland）
• Syneos Health（USA）
• Q2 Solutions（USA）
• Intertek Group plc（UK）
• Parexel International Corporation（USA）
• ACM Global Laboratories（USA）
• Frontage Laboratories, Inc.（USA）
• BioAgilytix（USA）
• KCAS Bioanalysis & Biomarker Services（USA）
• Pacific BioLabs（USA）

結論と提言

Bioanalytical Testing Services Market size was valued at USD 3.6 Billion in 2023 and is poised to grow from USD 4.18 Billion in 2024 to USD 13.9 Billion by 2032, growing at a CAGR of 16.2% during the forecast period (2025-2032).

The global bioanalytical testing services market encompasses analytical services provided to pharmaceutical, biopharmaceutical, and biotechnology industries to support drug development and research. These services involve analyzing biological samples-such as blood, urine, and tissues-to determine drug concentrations, metabolites, and biomarkers, thereby assessing drug safety, efficacy, and pharmacokinetics. Contract research organizations (CROs) and specialized service providers play a pivotal role in delivering these essential services. A primary objective of the bioanalytical testing services market is to furnish reliable and accurate testing to facilitate the introduction of safe and effective drugs into the market. However, several challenges impede market growth. Notably, the high costs associated with bioanalytical testing services can be prohibitive, particularly for smaller pharmaceutical companies and research institutions. Additionally, the complexity and technical difficulties inherent in bioanalytical testing can limit the efficiency and accuracy of results, leading to extended turnaround times and potential data interpretation issues. Moreover, the lack of standardization in analytical methods and procedures poses significant challenges. Variations in methodologies can lead to inconsistencies in data, complicating the comparison and validation of results across different studies and laboratories. This lack of uniformity can hinder the drug development process and delay regulatory approvals. Addressing these challenges necessitates concerted efforts to standardize analytical methods, invest in advanced technologies to streamline processes, and implement cost-effective strategies. Such measures are vital to overcoming existing barriers and fostering growth within the bioanalytical testing services market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Bioanalytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Bioanalytical Testing Services Market Segments Analysis

Global Bioanalytical Testing Services Market is segmented by Molecule, Test, Workflow, Application, End Use and region. Based on Molecule, the market is segmented into Small Molecule, Large Molecule and Others. Based on Test, the market is segmented into ADME, PK, PD, Bioavailability, Bioequivalence and Others. Based on Workflow, the market is segmented into Sample Preparation, Sample Analysis and Other Workflow Processes. Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology and Other Applications. Based on End Use, the market is segmented into Pharma & BioPharma Companies, CDMO and CRO. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Bioanalytical Testing Services Market

The escalating number of pharmaceutical trials and the intensified focus on developing new drugs and biopharmaceuticals are significantly boosting the demand for bioanalytical testing services. These services are crucial for ensuring the accuracy and reliability of data, which in turn guarantees the efficacy and safety of pharmaceutical products. As pharmaceutical companies invest more in research and development, there is a corresponding increase in the need for comprehensive bioanalytical testing to support drug development and regulatory approval processes.

Restraints in the Bioanalytical Testing Services Market

The substantial expenses associated with bioanalytical testing, particularly for advanced specialized analyses, can pose significant challenges for smaller pharmaceutical companies and research institutions. These high costs often serve as barriers, potentially hindering the progression of drug development projects within these organizations.

Market Trends of the Bioanalytical Testing Services Market

The integration of biomarker discovery into bioanalytical testing projects is gaining momentum, reflecting its critical role in personalized medicine, early diagnosis, and targeted therapies. Biomarkers-biological molecules measurable in blood, tissues, or other fluids-provide insights into normal or pathological processes and treatment responses. Their identification and validation are essential for diagnosing diseases, predicting outcomes, and tailoring treatments. Advanced technologies, such as mass spectrometry, genomics, and proteomics, facilitate the precise detection and quantification of these biomarkers. By leveraging these cutting-edge tools, bioanalytical testing services enhance the development of novel treatments and diagnostic tools, thereby advancing precision medicine and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Bioanalytical Testing Services Market Size by Molecule & CAGR (2025-2032)

• Market Overview
• Small Molecule
• Large Molecule
  • LC-MS Studies
  • Immunoassays
  • PK
  • ADA
  • Others
• Others

Global Bioanalytical Testing Services Market Size by Test & CAGR (2025-2032)

• Market Overview
• ADME
  • In-Vivo
  • In-Vitro
• PK
• PD
• Bioavailability
• Bioequivalence
• Others

Global Bioanalytical Testing Services Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Sample Preparation
  • Protein Precipitation
  • Liquid-Liquid Extraction
  • Solid Phase Extraction
• Sample Analysis
  • Hyphenated technique
  • Chromatographic technique
  • Electrophoresis
  • Ligand Binding Assay
  • Mass Spectrometry
  • Nuclear Magnetic Resonance
• Other Workflow Processes

Global Bioanalytical Testing Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Applications

Global Bioanalytical Testing Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Pharma & BioPharma Companies
• CDMO
• CRO

Global Bioanalytical Testing Services Market Size & CAGR (2025-2032)

• North America (Molecule, Test, Workflow, Application, End Use)
  • US
  • Canada
• Europe (Molecule, Test, Workflow, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Molecule, Test, Workflow, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Molecule, Test, Workflow, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Molecule, Test, Workflow, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Labcorp Drug Development (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Q2 Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intertek Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parexel International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACM Global Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Frontage Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioAgilytix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCAS Bioanalysis & Biomarker Services (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific BioLabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations